XML 25 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholder Equity (Deficit) (Unaudited) - USD ($)
$ in Millions
Total
Dun & Bradstreet Corp
Total Stockholder Equity (Deficit)
Total Stockholder Equity (Deficit)
Dun & Bradstreet Corp
Common Stock 
Common Stock 
Dun & Bradstreet Corp
Capital Surplus
Capital Surplus
Dun & Bradstreet Corp
(Accumulated Deficit) Retained Earnings
(Accumulated Deficit) Retained Earnings
Dun & Bradstreet Corp
Treasury Stock
Treasury Stock
Dun & Bradstreet Corp
Cumulative Translation Adjustment
Cumulative Translation Adjustment
Dun & Bradstreet Corp
Defined Benefit Postretirement Plans
Defined Benefit Postretirement Plans
Dun & Bradstreet Corp
Cash Flow Hedging Derivative
Cash Flow Hedging Derivative
Dun & Bradstreet Corp
Non-Controlling Interest
Non-Controlling Interest
Dun & Bradstreet Corp
Balance at beginning of period at Dec. 31, 2018 $ (13.5) $ (689.9) $ (13.5) $ (705.8) $ 0.0 $ 0.8 $ 0.0 $ 332.8 $ (13.5) $ 3,325.0 $ 0.0 $ (3,310.3) $ 0.0 $ (235.5) $ 0.0 $ (818.3) $ 0.0 $ (0.3) $ 0.0 $ 15.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income (loss) (74.8) [1]   (75.6)           (75.6)                   0.8  
Payment to non-controlling interest (0.1)                                   (0.1)  
Equity-based compensation plans 11.7   11.7       11.7                          
Pension adjustments, net of tax expense (benefit) 65.4   65.4                       65.4          
Change in cumulative translation adjustment, net of tax expense (benefit) 5.9 [1],[2]   5.7                   5.7           0.2  
Derivative financial instruments, net of tax expense (benefit) (0.1) [1],[3]   (0.1)                           (0.1)      
Balance at end of period at Feb. 07, 2019 (681.9)   (698.7)   0.8   344.5   3,249.4   (3,310.3)   (229.8)   (752.9)   (0.4)   16.8  
Balance at beginning of period at Dec. 31, 2018 (13.5) $ (689.9) (13.5) $ (705.8) 0.0 $ 0.8 0.0 $ 332.8 (13.5) $ 3,325.0 0.0 $ (3,310.3) 0.0 $ (235.5) 0.0 $ (818.3) 0.0 $ (0.3) 0.0 $ 15.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income (loss) (270.1) [1]   (272.0)           (272.0)                   1.9  
Take-Private Transaction 2,065.2   2,048.4       2,048.4                       16.8  
Capital / equity contribution 24.6   24.6       24.6                          
Preferred dividend [4] (32.0)   (32.0)       (32.0)                          
Payment to non-controlling interest (3.2)                                   (3.2)  
Equity-based compensation plans 59.5   59.5       59.5                          
Change in cumulative translation adjustment, net of tax expense (benefit) (16.9) [1],[2]   (16.8)                   (16.8)           (0.1)  
Derivative financial instruments, net of tax expense (benefit) (1.6) [1],[3]   (1.6)                           (1.6)      
Balance at end of period at Jun. 30, 2019 1,812.0   1,796.6   0.0   2,100.5   (285.5)   0.0   (16.8)   0.0   (1.6)   15.4  
Balance at beginning of period at Mar. 31, 2019 1,896.8   1,879.5   0.0   2,104.2   (223.5)   0.0   (0.8)   0.0   (0.4)   17.3  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income (loss) (60.5) [1]   (62.0)           (62.0)                   1.5  
Capital / equity contribution 24.6   24.6       24.6                          
Preferred dividend [4] (32.0)   (32.0)       (32.0)                          
Payment to non-controlling interest (3.2)                                   (3.2)  
Equity-based compensation plans 3.7   3.7       3.7                          
Change in cumulative translation adjustment, net of tax expense (benefit) (16.2) [1],[2]   (16.0)                   (16.0)           (0.2)  
Derivative financial instruments, net of tax expense (benefit) (1.2) [1],[3]   (1.2)                           (1.2)      
Balance at end of period at Jun. 30, 2019 1,812.0   1,796.6   0.0   2,100.5   (285.5)   0.0   (16.8)   0.0   (1.6)   15.4  
Balance at beginning of period at Dec. 31, 2019 1,577.7   1,519.9   0.0   2,116.9   (573.5)   0.0   (6.6)   (15.8)   (1.1)   57.8  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income (loss) (99.9) [1]   (101.5)           (101.5)                   1.6  
Accretion - Series A Preferred Stock (36.1)   (36.1)       (36.1)                          
Preferred dividend [4] (64.1)   (64.1)       (64.1)                          
Payment to non-controlling interest (0.3)                                   (0.3)  
Equity-based compensation plans 27.2   27.2       27.2                          
Pension adjustments, net of tax expense (benefit) (0.1)   (0.1)                       (0.1)          
Change in cumulative translation adjustment, net of tax expense (benefit) (14.9) [1],[2]   (13.7)                   (13.7)           (1.2)  
Derivative financial instruments, net of tax expense (benefit) (0.5) [1],[3]   (0.5)                           (0.5)      
Balance at end of period at Jun. 30, 2020 1,389.0   1,331.1   0.0   2,043.9   (675.0)   0.0   (20.3)   (15.9)   (1.6)   57.9  
Balance at beginning of period at Mar. 31, 2020 1,619.5   1,561.4   0.0   2,087.6   (500.0)   0.0   (8.3)   (15.9)   (2.0)   58.1  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                        
Net income (loss) (173.8) [1]   (175.0)           (175.0)                   1.2  
Accretion - Series A Preferred Stock (35.1)   (35.1)       (35.1)                          
Preferred dividend [4] (32.1)   (32.1)       (32.1)                          
Payment to non-controlling interest (0.1)                                   (0.1)  
Equity-based compensation plans 23.5   23.5       23.5                          
Change in cumulative translation adjustment, net of tax expense (benefit) (13.3) [1],[2]   (12.0)                   (12.0)           (1.3)  
Derivative financial instruments, net of tax expense (benefit) 0.4 [1],[3]   0.4                           0.4      
Balance at end of period at Jun. 30, 2020 $ 1,389.0   $ 1,331.1   $ 0.0   $ 2,043.9   $ (675.0)   $ 0.0   $ (20.3)   $ (15.9)   $ (1.6)   $ 57.9  
[1] See Note 1 "Basis of Presentation" for further discussion.
[2] Tax Expense (Benefit) of $(0.7) million, $$(1.9) million, $(0.9) million, $$(0.9) million, and less than $0.1 million for the Successor three months ended June 30, 2020 and 2019, for the Successor six months ended June 30, 2020, for the Successor period from January 1 to June 30, 2019, and for the Predecessor period from January 1 to February 7, 2019, respectively.
[3] Tax Expense (Benefit) of $0.1 million, $(0.4) million, $(0.2) million, $(0.5) million, and $(0.1) million for the Successor three months ended June 30, 2020 and 2019, for the Successor six months ended June 30, 2020, for the Successor period from January 1 to June 30, 2019, and for the Predecessor period from January 1 to February 7, 2019, respectively.
[4] Related to the preferred stock dividends declared by the Board of Directors of Dun & Bradstreet Holdings, Inc. (formerly Star Intermediate I, Inc.) on May 31, 2019, March 4, 2020 and May 14, 2020, respectively, associated with its cumulative Series A Preferred Stock. The dividend payments of $21.3 million, $10.7 million, $32 million and $32.1 million were made on June 19, 2019, June 28, 2019, March 27, 2020 and June 26, 2020, respectively. See further discussion in Note 17.